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We report on recent progress in the field of mobile tumor treatment with scanned particle beams, 
as discussed in the latest editions of the 4D treatment planning workshop. The workshop series 
started in 2009, with about 20 people from 4 research institutes involved, all actively working on 
particle therapy delivery and development. The first workshop resulted in a summary of recom-
mendations for the treatment of mobile targets, along with a list of requirements to apply these 
guidelines clinically. The increased interest in the treatment of mobile tumors led to a continu-
ously growing number of attendees: the 2012 edition counted more than 60 participants from 
20 institutions and commercial vendors. The focus of research discussions among workshop 
participants progressively moved from 4D treatment planning to complete 4D treatments, aim-
ing at effective and safe treatment delivery. Current research perspectives on 4D treatments 
include all critical aspects of time resolved delivery, such as in-room imaging, motion detection, 
beam application, and quality assurance techniques. This was motivated by the start of first 
clinical treatments of hepato cellular tumors with a scanned particle beam, relying on gating or 
abdominal compression for motion mitigation. Up to date research activities emphasize signifi-
cant efforts in investigating advanced motion mitigation techniques, with a specific interest in 
the development of dedicated tools for experimental validation. Potential improvements will be 
made possible in the near future through 4D optimized treatment plans that require upgrades 
of the currently established therapy control systems for time resolved delivery. But since also 
these novel optimization techniques rely on the validity of the 4DCT, research focusing on alter-
native 4D imaging technique, such as MRI based 4DCT generation will continue.
Key words: Particle therapy; Proton therapy; Beam scanning; Organ motion; Interplay; 4D.
Introduction
In this report of the 4th 4D treatment planning workshop held in Erlangen, 
 Germany in December 2012 we want to review the recent progress that has been 
made in the field of mobile tumor treatment with scanned particle beams with an 
emphasis on the contributions discussed within the workshop. 
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 The workshop series started in 2009 at the Paul Scher-
rer Institute (PSI), Villigen, Switzerland. About 20 people 
attended from 4 institutes (GSI Helmholtz Centre for Heavy 
Ion Research (GSI), Darmstadt, Germany, German Cancer 
Research Center (DKFZ), Heidelberg, Germany, University 
of Tübingen, Tübingen, Germany, PSI). A special report was 
published as a result of the discussions in the plenary sessions 
of the workshop (1). It summarizes recommendations for the 
treatment of mobile targets with actively scanned particles 
and contained a list of requirements to elaborate and apply 
these guidelines. The paper was awarded with the Swiss 
Society of Radiobiology and Medical Physics (SGSMP)/
Varian recognition award 2010. In 2010, the 2nd edition of the 
workshop was carried out at GSI with about 30 participants; 
the 3rd edition 2011 at the CNAO facility, Pavia, Italy already 
attracted more than 40 participants. To restore the original 
aim of the workshop, i.e., an informal platform to discuss 
current approaches, challenges and future research directions 
in 4D treatment planning, the participants agreed at the 4th 
edition of the workshop in 2012 at the University of Erlan-
gen-Nuremberg, Germany (about 60 participants from about 
20 institution including representative of commercial ven-
dors), that in the future, the number of participants per insti-
tute will be limited to two persons. To stimulate discussions 
on still confidential research projects and to enable an open 
controversy about failures, representatives of commercial 
vendors will be excluded. In return, an annual report will be 
established to summarize all novelty. The next edition of the 
workshop is planned in November 2013 at PSI, Switzerland. 
In the last years, the research on beam scanning for treatment 
of mobile tumors has finally led to first clinical applications, 
e.g., for hepato cellular tumors that are subject to respiratory 
motion (2). These clinical approaches can still be considered 
as first steps, i.e. research work has to continue, mainly in 
the fields outlined already in the previous report of Knopf 
et al. In that context, the scope changed from 4D treatment 
planning to complete 4D treatments, including appropriate 
imaging, motion detection, beam application, and quality 
assurance techniques suitable for the interplay prone irradia-
tion of mobile tumors with a scanned beam.
The structure of the report is geared to the outlook chap-
ter of the report summarizing the 1st workshop (1). We will 
focus on progress in 4D treatment planning options and 
in 4D treatment application techniques with an emphasis 
on contributions from participants of the workshop. For a 
broader overview on the field of the treatment of mobile 
tumors with scanned particle beam therapy please con-
sult one of the following recent review papers (3-5). Even 
broader knowledge on cross-cutting aspects such as motion 
monitoring for treatment of mobile tumors exists in the pho-
ton treatment community; for details we refer the reader to 
review articles (6-8).
Progress in 4D Treatment Planning
4D Dose Calculation
4D dose calculation is an essential part of 4D treatment and 
has been first reported for proton therapy almost a decade ago 
(9). Also for scanned particle beams research codes capable 
of 4D dose calculations have been established at several cen-
ters in the last years (10-14), providing the foundation for 
more advanced research as mentioned below. The codes 
include handling of proton as well as particle beams and apart 
from analytical codes also Monte Carlo based solutions have 
been reported (15-17). The advanced codes enable 4D dose 
calculations taking into account different delivery param-
eters as well as numerous realistic patient motion scenarios 
(11, 18). Thus, simulation of different application techniques 
(e.g., active vs. passive energy modulation, rescanning vs. 
beam tracking) as well as the patient specific reconstruction 
of treatment deliveries is possible (see section 5.4).
4D dose calculation is not limited to intra-fractionally moving 
tumors but also inter-fractionally changing geometries such 
as prostate cancer was studied and presented at the work-
shops. The motion phases are then from multiple days and, 
e.g., represent different rectum filling. Another intermediate 
approach between 3D and full 4D treatment planning is the 
dose calculation on repeated breath hold CTs. The robustness 
of proton treatment plans for lung cancer patients against 
interfractional variations during voluntary breath hold was 
recently studied in a master project carried out at PSI (19).
Based on the activity of the last years, codes for 4D dose 
calculation are no longer the bottleneck for precise studies 
assessing the dosimetric outcome of treatment techniques or 
even delivered treatments. The challenge in the next years 
will be the transition from research codes into a commercially 
available product and the development of robust deformable 
image registration codes since vector field are an essential 
input to 4D dose reconstruction algorithms. 
Motion Modeling for 4D Planning
As in 3D treatments, many of the 4D treatment planning 
approaches currently rely on the 4DCT acquired during 
treatment planning. This dataset represents a snapshot of the 
patient’s motion and many studies showed that the motion 
parameters change during the course of treatment and even 
within a few minutes (20-22). It is thus essential to exactly 
quantify the expected changes and their dosimetric influence 
and to develop solutions that overcome that clinical situa-
tion. In addition, the community needs to strive for better 
image guidance options which are still less advanced in par-
ticle therapy centers than in the photon treatment commu-
nity despite the fact that particle treatments can physically 
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be delivered more precisely. Then, e.g., 4D Cone-Beam CTs 
could be acquired of an immobilized patient and ideally be 
used in an online, adaptive treatment option (23).
The issue of accurate motion modeling in 4D treatment plan-
ning has been addressed by investigating the effects of breath-
ing irregularities in 4DCT (24). Higher correlation between 
external surrogates and internal lung motion was found for 
regular vs. irregular breathers, with prediction errors mostly 
dependent on the peak to peak range of motion. A novel 4D 
CT resorting technique based on the use of multiple surro-
gates has been also investigated: results show that monitor-
ing of multiple surrogates can handle the task of breathing 
phase detection more accurately, resulting in reduced image 
artifacts in presence of limited breathing irregularities (25).
To overcome the restriction of snap shot 4DCTs and to reduce 
imaging dose, PSI investigated, if 4D magnetic resonance 
imaging (MRI) data can be the basis for 4DCT generation, 
named 4DCT(MRI) (12). 4DMRI can be acquired over sev-
eral minutes since no ionizing radiation is applied. Boye et al. 
extracted motion vectors from the 4DMRI and wrapped them 
to stationary 3DCT to derive 4DCT(MRI)s with the help of 
motion modeling. 4DCT(MRI)s obtained in this way repre-
sent motion behavior over several breathing cycles including 
variations in amplitude and breathing frequency as well as 
baseline drifts. Thus, no assumptions on breathing regularity 
have to be made during 4D treatment planning. This enables 
the investigation of treatment plans against motion varia-
tions. Furthermore, motion variations can be considered in 
treatment plan optimization in order to obtain 4D optimized 
plans that are robust against expected variation such as phase 
shifts between motion surrogate and the actual tumor motion. 
4DCT(MRI)s can further be used to support motion monitor-
ing, as described in section 5.1.
Evaluation of Different Deformable Registration Methods
4D treatment planning heavily relies on deformable image 
registration. Numerous codes are available from vendors 
and within the research community. Since the application of 
those codes varies, also the research on their validation does. 
In a cross-center study, Brock et al. studied various codes 
for typical radiotherapy sites with respect to accuracy and 
reproducibility (26). They report large discrepancies in the 
reported shifts with a majority of the codes performing at 
voxel size level of the underlying dataset. 
Among the workshop participants, an automatic feature 
detection was proposed relying on the Scale Invariant Fea-
ture Transform (SIFT) method for validation of deformable 
image registration (27). The automated detection results are 
comparable to expert-user-based detection, and is applicable 
to both 4D CT and 4DMRI datasets (28). The method was 
studied in adaptive radiotherapy and showed that SIFT based 
metrics are correlated to detected anatomical changes over 
the course of treatment. Also the use of regularization meth-
ods in deformable image registration was analyzed, as a way 
to increase the physiological consistency of the quantified 
deformation field (29). This has been applied to head & neck 
treatments and requires extension to mobile sites, in order to 
establish optimal regularization parameters. 
A detailed study with respect to 4D dose calculation in 
scanned proton beams has been reported by Zhang et al. 
(18). For single-field treatments, where no motion mitiga-
tion was used a maximum (mean) dose difference (averaged 
over three cases) of 32.8% (2.9%) was observed with regards 
to the use of different deformable registration algorithms to 
extract motion information from 4D images. This registra-
tion ambiguity-induced uncertainty indicate the necessity to 
interpret 4D dose distributions for scanned proton therapy as 
approximation, inevitably bonded with error bars. Quantifi-
cation and presentation of deviations in 4D treatments is an 
essential topic in itself. Not only the registration quality but 
also many of the other parameters such as internal-external 
correlation of motion monitoring devices or assumptions in 
the treatment application technique are prone to uncertain-
ties. Hild et al. proposed different quantification options on 
the basis of 4D treatment plans for lung tumors (30).
Lüchtenborg used different registration options in a treatment 
planning study assessing beam tracking (31). They report, 
that rigid registrations should be used for calculation of beam 
tracking parameters since distances are preserved which is 
essential if over/under-doses due to changes in spacing of 
Bragg-peaks should be avoided. 
4D Treatment Plan Optimization
4D treatment plan optimization can be classified as the 
explicit incorporation of motion data into the cost function of 
the optimization. It has been reported especially in the photon 
community since several years (32) also within the context of 
our workshop series, which included the studies of Suh et al. 
(33, 34).
The potential of 4D optimized treatment plans are one of the 
results of a recent study of Knopf et al. (35). They studied the 
consequences of different beam weight distributions when 
treating mobile targets. For static targets, beam weights were 
optimized in order to achieve best target dose conformity. 
This usually results in many low weighted spots and a few 
high weighted spots at the distal edge of the target. For the 
treatment of mobile tumors target dose conformity is com-
promised by blurring, thus different beam weight optimi-
zation objectives might be considered. In their preliminary 
study it was shown that treatment plans with a “smooth” 
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beam weight distributions are significantly more robust when 
treating moving targets with scanned proton beams (36). By 
designing appropriate robustness constraints, such smooth 
distribution could be the outcome of a treatment plan opti-
mized in 4D.
Eley et al. investigated the possibilities of 4D optimization 
in beam tracking with a scanned carbon beam (37). They 
investigated for an artificial geometry as well as for a lung 
tumor patient, if 4D optimized treatment plans could reduce 
the dose to nearby organs at risk. The GSI in-house treat-
ment planning system was thus extended to fully incorporate 
4DCTs and deformation maps in the optimization process. 
They found comparable target coverage for both cases and a 
reduced maximal dose to the heart as organ at risk. 
The work is complemented by Graeff et al., who developed 
a more general framework for 4D optimization based on sub-
dividing the target volume to ease the technical demands in 
the optimization. This is promising or even essential, since 
memory and calculation time demands might be too high, 
if all (typically ∼10) motion states are incorporated without 
further constraints. The sub-sections of the target volume are 
chosen with respect to the delivery constraints. The authors 
showed for nine lung cancer patients that highly conformal 
target dose distributions can be achieved without detrimental 
inverse interplay patterns in the entrance channel which are 
typically observed in beam tracking plans (38). An alterna-
tive approach is reported by Graeff et al. in this issue.
As in 4D dose calculation, also 4D optimization still relies on 
precise 4DCT and deformation vector field data. Appropri-
ate procedures and/or techniques have to be established and 
assessed prior clinical use (see also section 4.2).
Strategies for 4D Treatment Planning Studies
Due to interplay effects, the dose homogeneity throughout 
the target is the main concern in the treatment of mobile tar-
gets with scanned particle therapy. Different homogeneity 
benchmarks are reported. It was proposed to unify the report-
ing of DVH parameters to make studies more comparable. 
The proposed, already well-established parameters include: 
D5-D95 for the homogeneity of the target dose, V95 to quan-
tify target coverage, and V107 for overdose. For dose confor-
mation, the conformity number (CN) as described by van’t 
Riet (39) is proposed.
It should be noted, that quantification of treatment techniques 
for moving tumors with a scanned beam should be based on 
multiple simulations or measurements using different param-
eters for both target motion and beam application. Due to 
interplay, all techniques will be influenced by the specific 
interference pattern of an individual irradiation (40) and thus 
a single outcome is not representative for the potential of a 
technique. 
Experimental Validation of 4D Treatments
Experimental validation of implemented 4D treatment 
options is essential since the technical demands of the treat-
ment delivery systems are often much higher than for 3D 
treatments and can thus be the bottleneck of potential solu-
tions. Validation requires adequate motion phantoms with 
detections systems. A list of phantom features was reported 
in the previous workshop report (1).
Each group performing experiments focusing on moving 
targets uses motion platforms, either commercial solutions 
or in-house built. These devices allow typically a one- 
dimensional (translational or rotational) motion which is 
not representing a patient geometry but often sufficient for 
an initial study of a new technique. It is then the preferred 
technique due to easy handling but investigators have to keep 
in mind that study results might not be transferable to patient 
geometries. The platforms can carry radiographic films (40), 
scintillation detectors (41), biological probes (42), probes for 
positron emission tomography (PET) measurements (43), or 
water phantoms with ionization chambers (44).
Recently, developments focused on complex phantoms that 
should mimic the patient geometry. Zakova et al. together 
with the Centre Suisse d’Electronique et de Microtechnique 
(CSEM) currently develop an anthropomorphic thorax phan-
tom which is completely metal-free and CT as well as MRI 
compatible (45). Motion can be controlled by air inflation 
into an air-tight lung, which is surrounded by a realisticly 
expanding rib cage. The dose distribution can be recorded 
with an ionization chamber or Gafchromic films placed 
directly into a tumor moving within the lung compartment. 
First irradiation tests with a scanned proton beam showed 
that the phantom allows extensive dosimetric studies under 
realistic circumstances (45). Steidl et al. report about a robot 
based thorax phantom which is used for validation studies in 
scanned carbon beams (46). A robotic arm is used to move a 
lucite block mimicking the tumor and equipped with radio-
graphic films and 20 ionizations chambers. The tumor can 
move in 6D and motion is in correlation with an independent 
thorax phantom that is based on a plastic skeleton covered 
by rubber representing the skin. Initial tests with and without 
beam have been successful (46) and the phantom has since 
been used in a number of 4D validation studies (11, 47).
On the experimental side, the feasibility and efficacy of the 
advanced scanning techniques was tested systematically in 
numerous studies. Rescanning (41), gating (48), beam track-
ing (44, 49) as the main motion mitigation techniques, but 
also the validity of 4D treatment planning systems (11, 38, 50) 
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have been studied. More details will be reported in section 5 
covering the mitigation techniques itself.
Validation further includes in vivo dosimetry. An established 
method for ion beam therapy is the in-beam and offline use 
of PET. Carbon-11 and C-10 that result of fragmentation 
of the primary C-12 beam serve as positron emitters (51). 
In the last years the Helmholtz-Centre Dresden Rossendorf 
(HZDR), GSI and HIT worked on 4D extensions for in-beam 
PET within the EU funded projects ULICE and ENVISION. 
Laube et al. reported on simulations, reconstruction methods 
and experimental results for 4D in-beam PET (43, 52). The 
proposed methods are suitable to judge the relevant param-
eters for treatments of intra-fractionally moving tumors with 
a scanned carbon beam. Initial steps towards routine imple-
mentation at the HIT facility have been successful (17).
Activities based on 4D PET further focused on the use of 4D 
CT motion models to optimize 4D PET imaging (53, 54). 
Such an optimization can either be applied to treatment plan-
ning 4D PET/CT studies or to post-irradiation PET imaging 
(PET-based dosimetry), in order to make the most of the 
reduced count statistics induced by particle irradiation. 
Despite all efforts, validations will always lack the clinical 
scenario and typically focus on one special technique (e.g., 
motion phantoms to validate motion monitoring systems 
that do not allow dosimetric quantification or assessment of 
deformable image registration). Thus, careful introduction of 
new techniques into clinical application has to follow despite 
potential shortcomings accompanied by, e.g., the proposed 
in vivo dosimetry techniques and stringent follow-up of the 
patients.
Progress in Beam Application Techniques
Treatment of intra-fractionally moving organs will require 
dedicated means if scanned beams are chosen as treatment 
technique. In the context of this manuscript we will refer to 
all procedures as techniques and report the current status of 
the involved groups. Many of them require precise motion 
monitoring and often also margins forming the internal target 
volume (ITV) from the clinical target volume (CTV).
Motion Monitoring and Motion Prediction
Volumetric methods such as 4DCT or 4DMRI are used as 
part of motion modeling in treatment planning to describe 
the anatomy for dose calculation and treatment plan optimi-
zation. During treatment delivery these methods are not (yet) 
available, despite first approaches to combine photon linacs 
and MRI exactly for this purpose (55). Thus, 1D motion sig-
nals or motion surrogates are frequently used for the purpose 
of detecting the 4DCT state or the 3D position of a marker 
in real-time during treatment delivery (3, 56). Especially 
for precise treatment techniques like beam tracking (section 
5.5), surrogates are not ideal due to potential miscorrelation 
to the internal targets. Vice versa, purely fluoroscopic based 
detection of radio-opaque fiducials offers precise motion 
information, but results in additional x-ray doses (57) even 
though these can be at dose levels comparable to other image 
guidance options (58). Thus, alternative techniques have 
been studied.
In order to precisely track tumor motion online it is essential 
to obtain information on the 3D motion vector throughout the 
region of interest. Any sparsely acquired surrogate motion is 
generally not sufficient to describe the deformable behavior in 
three dimensions. In a recent study, it has been shown that 3D 
deformable motions can be estimated from surrogate motions 
obtained from either BEV or dual X-ray imaging systems for 
treatments in the liver (59, 60). The method requires motion 
sampled over a number of breathing cycles for each patient 
before treatment using some form of 4D imaging, for exam-
ple 4DMRI. On the base of this motion library a Principle 
Component Analysis (PCA) can be applied to build subject 
specific motion models. Motion models based on markerless 
surface detection have also been explored, relying of deform-
able surface registration to achieve accurate motion monitor-
ing of specific anatomical landmarks (61). 
3D real-time data without ionizing radiation can be mea-
sured by ultrasound as shown by several groups for inter-
fractional motion assessment (organ positioning) (56). For 
intra-fractional motion monitoring, Jenne et al. reported the 
use of ultrasound at the 4th workshop in Erlangen. By means 
of dedicated transducers a 2D plane of the patient can be 
scanned. Either the tumor is visualized directly, or internal 
surrogates such as the diaphragm are used. If combined in 
two directions, pseudo-3D data are achieved. The feasibility 
of ultrasound based beam tracking has been reported by Prall 
et al. (62). They showed that delay compensation is possible 
via neural networks and present experimental data indicat-
ing the feasibility of ultrasound based compensation without 
tracking parameters from treatment planning.
At DKFZ motion monitoring using the Calypso-System 
(Medical Systems Inc., Palo Alto, CA) for internal pros-
tate motion and more recently also for lung tumor motion 
was studied (63). The system uses field generating coils to 
be implanted inside or close to the tumor whose position is 
detected by an electromagnetic detector array. Thus no addi-
tional radiation dose is applied to the patient and real time 
tumor motion tracking is feasible (64, 65). Recent attempts 
are trying to use the system also for proton therapy (66). In 
case of tumor tracking accurate and real-time tumor motion 
detection is required. To overcome the problem of system 
latencies additional emphasis has been put on the evaluation 
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of motion prediction algorithms for real-time tumor tracking. 
The study of Krauss et al. emphasized the relative impor-
tance of adequate model parameter optimization compared to 
the actual prediction model selection (67).
A combination of internal motion detection and surrogates 
can be achieved by dedicated correlation models. The group 
at Politechnico Milano studied several options, focusing 
on the accuracy of different correlation models by retro-
spective clinical data analysis (68-70). The issue of adap-
tive modeling and robustness of the correlation function of 
controlled breathing irregularities has been quantified (69, 
70). To show feasibility within the scanned particle therapy 
framework, model based motion detection has been used for 
beam tracking at GSI (47) (see also section 5.5 and Fattori 
et al. in this issue).
An alternative technique could be particle radiography which 
has been proposed for different purposes for decades (71, 72). 
With current technology, radiography as well as tomography 
is possible (73, 74), but so far not used for intra-fractional 
target motion detection. Preliminary work has been carried 
out to study the potential of particle radiography to monitor 
soft tissue motion (75, 76). In these studies, prior knowledge 
represented by the treatment planning CT is used to enhance 
the soft tissue contrast, so that particle radiography can be 
optimized for motion detection in soft tissue targets, avoiding 
the use of implanted surrogates to reach adequate accuracy.
Margin-based Approach
Intra-fractional motion is typically dealt with by using mar-
gins surrounding the CTV. ICRU report 62 (77) advises 
that variations in size, shape and position of CTVs relative 
to anatomic reference points can be considered for ITVs. In 
addition to geometrical margin adaption, changes of water 
equivalent path length have to be considered for particle ther-
apy, as already mentioned in the proton report of the ICRU 
(78). These considerations are applied since several years in 
passively shaped particle therapy but are often based on, e.g., 
overwriting of CT-numbers in the planning CT (79). 
A number of years ago, Engelsman et al. (80) proposed to 
use 4DCT as basis of ITV definition in scattered proton beam 
therapy. The work has been implemented for scanned beams 
as well (81, 82) but the original implementation is limited 
to single-field uniformal dose approaches because of field-
specific mapping of motion induced changes in particle range 
and uses out-dated dose calculation models. A full consider-
ation that is also applicable to intensity modulated particle 
therapy (IMPT) has been reported by Graeff et al. (83). They 
transform the geometrical ITV into a field-specific water-
equivalent path length ITV and use several motion phases 
to model the motion depended shape of the range-adapted 
ITV. The proposed method has been tested successfully on 
the data of a lung cancer patient.
A recent study by Knopf at al. shows that CTVs significantly 
differ in size from geometrical ITVs and range adapted ITVs 
(35). Furthermore, range adapted ITVs and geometrical ITVs 
differ significantly in size and are spatially displaced, particu-
larly for lung patients. Range-adapted ITVs show a strong 
field dependency in shape. 
Rescanning
One way to overcome interplay effects are multiple irradia-
tions per treatment fraction, referred to as rescanning (84). 
For acceptable treatment times this approach requires high 
scan speeds and thus also fast beam monitoring systems. In 
case of treatment plan application times within minutes, also 
(multiple) breath-hold based approaches are then feasible. 
There exist many possible rescanning strategies and nam-
ing schemes (scaled/slice-by-slice/level vs. iso-layered vs. 
volumetric/uniform, (85, 86)). In simulations by Zenklusen 
et al. (86) it was shown that continuous line scanning seems 
to be the most elegant solution: it provides higher repaint-
ing rates and produces superior results but is probably more 
difficult to realize. Recently the effectiveness of volumetric 
and slice-by-slice rescanning was investigated in relation to 
slow and fast beam delivery systems by Bernatowicz et al. 
(87). Similar effect to rescanning can be achieved with mul-
tiple fields per plan (10) or by using dedicated fractionation 
schemes (88).
Rescanning is a strong approach to mitigate interplay effects, 
but it does not address dose blurring due to motion. There-
fore, it is believed that best results can be obtained by com-
bining rescanning with other motion mitigation techniques 
and/or margins. At NIRS, most likely rescanning will be 
combined with gating and referred to as phase-controlled 
rescanning (PCR) (89). They reported several technical and 
simulation studies in the last years and are close to treat the 
first patient. Also at PSI rescanning alone is only seen as first 
level of motion mitigation. As a next step it is foreseen to use 
gated rescanning or slow tracking (35, 60). The second refers 
to a treatment during repeated breath holds with an adaption 
of the beam position for possible variation between different 
breath holds. As ultimate solutions 4D optimized rescanning 
or beam tracking and retracking (90) is envisioned.
Gating
Gating has been the method of choice for lung and liver 
treatments with a scattered carbon beam at NIRS for 10 
years (91). Based on motion monitoring data (section 5.1), 
the beam is only turned on in a defined part of the breath-
ing cycle, typically at end-exhale. Thus, the effective motion 
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amplitude is reduced. Also for scanned beam delivery this 
approach will reduce the interplay effects, but gating alone 
will not result in homogeneous CTV coverage since also 
reduced amplitudes induce interplay effect. NIRS thus com-
bines gating with rescanning (PCR, see previous section). 
An alternative seems to be irradiation with increased beam 
overlap, e.g., larger beam spot sizes at identical raster grid 
spacing as for stationary tumors (48). Based on numerous 
simulations and experimental studies of GSI and HIT (92, 
93) that included assessment of the sensor delays (94) and 
dosimetric verification (95), gating was recently introduced 
clinically for the treatment of hepato cellular cancer at HIT 
(2). Apart from gating, mainly abdominal compression was 
used to control the motion extent of the patient, but the 
required mitigation approaches are similar since in each case 
the interference effect of residual motion amplitudes needs 
to be compensated. Richter et al. recorded the motion sur-
rogate trace and the scanner progress data during treatment 
delivery of each fraction and used the GSI in-house 4D treat-
ment planning system to reconstruct the delivered 4D dose 
distribution for each fraction and for the complete treatment. 
Even though the focus of that study was feasibility of the pro-
posed method, they could show appropriate CTV coverage 
for a number of patients (96).
Beam Tracking
Beam tracking uses data from motion monitoring and poten-
tially 4D treatment planning to compensate target motion 
by adaptation of the scanned pencil beam (49, 97). Previ-
ous studies concentrated on simple phantom geometries and 
had the goal of feasibility checks since the application and 
therapy control needs are challenging. With respect to sys-
tem performance (98) but also dosimetrically (49, 99, 100), 
beam tracking works precisely. In case of non-translational 
motion, e.g., rotations, adjustment of the pencil beam posi-
tion is insufficient since the pre-irradiation mainly of proxi-
mal parts of the target by distal iso-energy layers changes. 
Luchtenborg et al. studied this influence and proposed an 
adaption of deposited particle numbers combined with real-
time calculations as solution (44). 
In 2012, experiments were conducted and reported at the 4th 
4D treatment planning workshop that extended from sim-
ple phantoms to complex, patient-like geometry. Scenarios 
based on the robotic thorax phantom presented in section 4.6 
were studied using correlation model based motion monitor-
ing solutions from the Politecnico Milano group (see section 
5.1). The experiments included baseline drifts of the tumor 
and correlation mismatch between thorax surface and tumor 
which will cause dose deviations if beam tracking delivery 
is fully based on the optimized 4D treatment plan. Thus, in 
the lateral plane, compensation offsets were directly deter-
mined in the motion monitoring system which can therefore 
compensate changes with respect to the treatment planning 
4DCT scan such as baseline drifts. Integration of the system 
(see Fattori et al., this issue), motion correlation models (47), 
and also the dosimetric outcome worked as expected. Beam 
tracking is thus on the verge to commercial implementation 
or research based clinical assessment.
Delivery of 4D Optimized Treatment Plans
4D optimization incorporates the different phases of the 
4DCT data in treatment plan optimization. Apart from dedi-
cated ITV concepts, these algorithms can also result in a 4D 
treatment plan, i.e. parameter files that are dependent on the 
motion phase of the patient. Such plans require a dedicated 
treatment control system which is more complex than for 3D 
treatments and of similar but different complexity to particle 
number compensated beam tracking. Such a control system 
has been implemented at GSI and its feasibility has been 
shown for different flavors of 4D optimization.
For both 4D optimization methods described above, the treat-
ment plan consists of a set of 3D plans to be delivered to 
specific motion phases. The treatment control system thus 
switches between these plans according to a motion moni-
toring signal. Depending on target geometry and the irradia-
tion sequence determined by the target motion, some motion 
phases do not or no longer require irradiation. In this case, 
the beam is gated during this motion phase. Smooth delivery 
thus requires fast, multiple gating during a spill. Delivery can 
be greatly facilitated by intensity control and flexible spill 
timing.
It should be noted that for these methods, the sequence of 
beam spots is determined online by the actual measured 
motion. A specific scanpath as for 3D delivery can thus not 
be preplanned. For both methods, the feasibility of delivery 
was shown in a film experiment (38).
Concluding Remarks
Scanned particle beam application to intra-fractionally 
moving tumors are still challenging, but the developments 
reported within the scope of the four 4D treatment planning 
workshops and on other occasions show that methods and 
techniques have been developed that will allow safe treat-
ment deliveries at several centers with a strong research focus 
in the near future. First patients have already been treated 
at HIT with a scanned carbon beam and gating or abdomi-
nal compression as motion mitigation technique and at 
Rinnecker Proton Therapy Center in Munich, Germany using 
apnea. PSI will rely on rescanning and potentially gating, 
NIRS plans to mimic scattered beam applications by rescan-
ning used in combination with beam gating as in the current 
clinical practice.
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The achievements reported above are predominantly reported 
by and implemented in centers with a strong research focus. 
One of the main challenges will be the transition of those 
ideas into medical products that vendors can offer to all facil-
ities of the meanwhile fairly broad particle therapy commu-
nity using beam scanning. While many of the new machines, 
e.g., can provide fast beam gating, there is typically no 4D 
treatment planning functionality available that would support 
parameter choices based on assessment of the expected 4D 
dose distribution. One potential reason for that slow transi-
tion into products could be the zoo of options reported from 
the research community with no clear component portfolio 
visible yet. For each of the required technologies (motion 
monitoring, motion mitigation, treatment planning, …) there 
are several options available, some of them even in clinical 
use, such as correlation model based motion monitoring, as 
in the Cyberknife Synchrony or the Brainlab/Mitsubishi Vero 
system, but the required or at least beneficial integration into 
a particle therapy center is not yet available. Many of those 
options were developed for photon radiotherapy, another 
indication that the particle therapy community still applies 
other standards than the modern photon therapy techniques. 
Similar for 4D verification systems and a quality assurance 
workflow, which was not covered in sufficient detail in this 
workshop series but which will require new ideas due to the 
random and thus not really predictable manner of interplay 
effects. That integration might speed up in case of standard-
ization, i.e. defined protocols for, e.g., the beam delivery 
sequence or the motion monitoring signal such that different 
4D treatment planning systems could import the data for cal-
culation of the delivered 4D dose distribution.
From a research perspective there is still the need for precise 
and three dimensional motion monitoring, ideally includ-
ing the range of the particle beam. Potential solutions, such 
as 4DCT(MRI) in combination with a surrogate and a PCA 
based model have been proposed recently (12, 60) and also 
4DPET or prompt-γ imaging might allow real-time options 
at some point. Ideally, such precise imaging options have to 
be combined with (real-time) treatment plan adaptation algo-
rithms to allow precise treatments of moving organs even in 
hypofractionated or even single-fraction treatment schedules 
(stereotactic body particle radiosurgery). The management 
of variable uncertainties including interplay effects in fewer 
fractions becomes even more challenging since the fraction-
ation itself will not lead to mitigation of dose inhomogene-
ities (10, 101, 102). Still, such fractionation schemes proved 
to be effective in clinical studies at NIRS (103) and thus 
wide-spread use can be anticipated not only because they are 
preferred by many patients.
For the still pretty young workshop series and future genera-
tion of researchers these challenges are motivating and the 
clinical results of the first patients treated with the advanced 
mitigation techniques mentioned within the scope of this 
report will certainly trigger new ideas. The next option to 
exchange experiences and details within that field will be the 
5th workshop, taking place at PSI in Villigen, Switzerland 
on November 28/29 2013. Interested colleagues – especially 
radio-oncologists – can contact one of the authors. 
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